Identification of N-Terminally Truncated Derivatives of Insulin Analogs Formed in Pharmaceutical Formulations

PURPOSE: Isolation and identification of unknown impurities of recombinant insulin lispro (produced at IBA) formed during accelerated stability testing of pharmaceutical solutions. For comparative purposes also commercially available formulations of recombinant human insulin (Humulin S®; Lilly), rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Zielińska, Joanna, Stadnik, Jacek, Bierczyńska-Krzysik, Anna, Stadnik, Dorota
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5956049/
https://www.ncbi.nlm.nih.gov/pubmed/29770892
http://dx.doi.org/10.1007/s11095-018-2426-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5956049/
https://www.ncbi.nlm.nih.gov/pubmed/29770892
http://dx.doi.org/10.1007/s11095-018-2426-1

Ejemplares similares